F-star Therapeutics, Inc.
FSTX · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,407 | -$18,994 | -$12,087 | $4,741 |
| Dep. & Amort. | $189 | $154 | $187 | -$607 |
| Deferred Tax | $0 | $0 | $0 | -$569 |
| Stock-Based Comp. | $1,446 | $1,416 | $1,454 | $1,344 |
| Change in WC | -$4,489 | -$1,079 | -$2,135 | $970 |
| Other Non-Cash | $4,713 | $1,971 | $966 | $902 |
| Operating Cash Flow | -$16,548 | -$16,532 | -$11,615 | $6,781 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$37 | -$235 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $38 | -$121 | $0 | $0 |
| Investing Cash Flow | $1 | -$356 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $41 | $320 | $1,949 | $1,051 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5 | $303 | $1,879 | $1,051 |
| Financing Cash Flow | $5 | $303 | $1,879 | $1,051 |
| Forex Effect | -$853 | $747 | -$12 | -$333 |
| Net Chg. in Cash | -$17,395 | -$15,838 | -$9,748 | $7,499 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52,963 | $68,801 | $78,549 | $71,050 |
| End Cash | $35,568 | $52,963 | $68,801 | $78,549 |
| Free Cash Flow | -$16,585 | -$16,767 | -$11,615 | $6,781 |